Rdea806

HCID 16221816

기본 정보

CAS
1004523-72-1
표준 SMILES
O=C(CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12)Nc1ccc(C(=O)O)cc1Cl
InChIKey
MPNGLQDRSJNLPL-UHFFFAOYSA-N
분자식
C24H18BrClN4O3S
평균 분자량
557.8 g/mol
단동위원소 질량
555.99715

이름 및 식별자

우선 이름
Rdea806
IUPAC
4-[[2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetyl]amino]-3-chlorobenzoic acid
영어명
Benzoic acid, 4-[[2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl) -4H-1,2,4-triazol -3-yl]thio]acetyl]amino]-3-chloro-
분자식
C24H18BrClN4O3S
분자량
557.84672

이름 및 동의어

RDEA806RefChem:875196878670-61-2RDEA-806 free acidRDEA 806RDEA-8061004523-72-1363Z97G83I4-(2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetamido)-3-chlorobenzoic acidUNII-363Z97G83IBenzoic acid, 4-((((5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)acetyl)amino)-3-chloro-VRX-806
이름 더 보기
RDEA806 free acid,RDEA 806 free acid4-[[[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]acetyl]amino]-3-chlorobenzoic acid4-[[2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]acetyl]amino]-3-chlorobenzoic acidBenzoic acid, 4-[[2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl) -4H-1,2,4-triazol -3-yl]thio]acetyl]amino]-3-chloro-
4-(2-(5-Bromo-4-(L-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio) acetamido-3-chlorobenzoic acid4-[[2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetyl]amino]-3-chlorobenzoic acidBenzoic acid, 4-((2-((5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)acetyl)amino)-3-chloro-Benzoic acid, 4-[[[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]acetyl]amino]-3-chloro-RDEA806 FREE ACIDSCHEMBL248221orb1737826CHEMBL1630216

데이터베이스 식별자

CAS
1004523-72-1、878670-61-2
PubChem CID
16221816
DTXSID
DTXSID50143299
ChEMBL
CHEMBL1630216
UNII
363Z97G83I

물성

구조 계산 물성

XLogP
6.2
극성 표면적
122 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
6
회전 가능 결합 수
7
무거운 원자 수
34

물리화학적 성질

밀도
1.69 · 1.69
산도 계수 (pKa)
3.87 · 3.87±0.10(Predicted)

화학 및 산업

약리 정보

Pharmacodynamics · 1건

RDEA806 is a potent HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to resistance and a broad spectrum of activity. RDEA806 is highly active in vitro against wild-type and the majority of HIV strains carrying key reverse transcriptase mutations. RDEA806 has the potential to be used in both naive and treatment-experienced patients and has a much higher barrier to resistance than currently approved NNRTIs, which could translate into delayed onset of resistance.

Mechanism of ActionRDEA806 binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzyme's catalytic site.

공급사6 곳

上海美洛英特化学有限公司15821661757 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
济南睿思医药技术有限公司0531-0531-69900633 19963472814 · [email protected]
重庆卡兰医药有限公司[email protected]

관련 반응

19건

화합물 노트

불러오는 중…